Showing results (81-90 of 166) with videos related to

Sort By:
Pageof 17
The Tohoku Journal of Experimental Medicine|May 1, 2022
TM5614, an Inhibitor of Plasminogen Activator Inhibitor-1, Exerts an Antitumor Effect on Chronic Myeloid LeukemiaKatsuyuki Sasaki, Tohru Fujiwara, Tetsuro Ochi, et al.
Annals of Hematology|September 18, 2012
Clinical and genetic characteristics of congenital sideroblastic anemia: comparison with myelodysplastic syndrome with ring sideroblast (MDS-RS)Rie Ohba, Kazumichi Furuyama, Kenichi Yoshida, et al.
CEN Case Reports|May 17, 2018
Concurrent isolated IgG2-positive membranous nephropathy and malignant B-cell lymphomaSatoshi Shimada, Takashi Nakamichi, Gen Yamada, et al.
Annals of Hematology|December 18, 2024
Angioimmunoblastic T-cell lymphoma harboring a t(8;14)(q24;q11.2)/TCR::MYC translocation that presented with intestinal infiltrationSatoshi Ichikawa, Hiroki Kato, Naoya Morota, et al.
International Journal of Hematology|December 28, 2022
Long-term safety profile of tirabrutinib: final results of a Japanese Phase I study in patients with relapsed or refractory B-cell malignanciesWataru Munakata, Kiyoshi Ando, Masahiro Yokoyama, et al.
Japanese Journal of Clinical Oncology|August 29, 2020
Phase 1b study to investigate the safety and tolerability of idelalisib in Japanese patients with relapsed/refractory follicular lymphoma and chronic lymphocytic leukemiaNoriko Fukuhara, Tomohiro Kinoshita, Kazuhito Yamamoto, et al.
Haematologica|August 24, 2014
GATA2 regulates differentiation of bone marrow-derived mesenchymal stem cellsMayumi Kamata, Yoko Okitsu, Tohru Fujiwara, et al.
Annals of Hematology|May 1, 2014
Identification of acquired mutations by whole-genome sequencing in GATA-2 deficiency evolving into myelodysplasia and acute leukemiaTohru Fujiwara, Noriko Fukuhara, Ryo Funayama, et al.
International Journal of Hematology|November 10, 2025
Efficacy and safety of fixed-duration venetoclax plus obinutuzumab in untreated Japanese CLL and SLL: a phase 2 studyKoji Izutsu, Mitsumasa Watanabe, Tomomi Toubai, et al.
Leukemia|January 7, 2026
Advances in the treatment and prognosis of aggressive NK-cell leukemia: results from the ANKL22 studyAyumi Fujimoto, Takeshi Maeda, Noriko Doki, et al.
Pageof 17